Duchenne Muscular Dystrophy Market by Therapy Class (Corticosteroids and Steroid Analogs, Exon-Skipping / Antisense Oligonucleotide Therapies, Gene Therapies, HDAC Inhibitors, Cell Therapies, Small-Molecule Muscle Protection Therapies and Supportive and Symptomatic Therapies), Genetic / Mutation Target, Technology Platform, Route of Administration, Distribution Channel, End User / Care Setting, Geographical Regions, and Leading Players – Trends and Forecasts, 2026-2040